Related Experiment Video

Updated: Dec 25, 2025

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.1K

Pediatric use of omalizumab for allergic asthma

Giovanni Battista Pajno1, Riccardo Castagnoli2, Stefania Arasi3

  • 1Department of Pediatrics, Allergy Unit, University of Messina , Messina, Italy.

Expert Opinion on Biological Therapy
|April 4, 2020
PubMed

Insights

Severe pediatric asthma, particularly Th2-high inflammation, can be effectively treated with anti-IgE therapy like omalizumab. This approach offers a personalized medicine option for children aged six and older with severe allergic asthma.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Allergy

Background:

  • Severe pediatric asthma is a heterogeneous condition with significant morbidity and economic impact.
  • Th2 inflammation with elevated IgE is the predominant endotype in childhood severe asthma.
  • Personalized medicine approaches are needed to address diverse pathomechanisms.

Purpose of the Study:

  • To review the role of omalizumab as a treatment for severe allergic asthma in pediatric patients (aged 6 years and above).

Main Methods:

  • Review of clinical trials and observational studies on omalizumab efficacy and safety in pediatric asthma.
  • Focus on anti-IgE therapy targeting IgE in Th2-high inflammation.

Main Results:

  • Omalizumab demonstrates well-documented clinical efficacy and safety in pediatric asthma patients.
  • Anti-IgE therapy is a potent therapeutic option for severe pediatric asthma with Th2 inflammation.

Conclusions:

  • Omalizumab is a valuable treatment for severe allergic asthma in children aged six and older.
  • Further research is needed on airway remodeling, biomarkers, and use in younger children.
Abstract

Keywords:
Asthmabiologicschildrendifficult-to-treat asthmaomalizumabprecision medicinesevere asthma

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

10.7K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.1K

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150